+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bladder Cancer Drugs Market Research Reports

From
From
Bladder Cancer Market and Forecast Analysis - Product Thumbnail Image

Bladder Cancer Market and Forecast Analysis

  • Report
  • July 2018
  • 199 Pages
  • Global
From
Bladder Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1855 Pages
  • Global
From
Bladder Cancer: Epidemiology Forecast to 2028 - Product Thumbnail Image

Bladder Cancer: Epidemiology Forecast to 2028

  • Report
  • February 2020
  • 49 Pages
  • Global
From
Bladder Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Bladder Cancer Treatment Drugs Markets in China

  • Report
  • June 2023
  • 235 Pages
  • China
From
Bladder Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Bladder Cancer Treatment Drugs Companies in China

  • Report
  • June 2023
  • 66 Pages
  • China
From
Global and Chinese Cisplatin Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Cisplatin Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 142 Pages
  • China, Global
From
Loading Indicator

The Bladder Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat bladder cancer. Bladder cancer is a type of cancer that affects the urinary tract and is the sixth most common type of cancer in the United States. Common treatments for bladder cancer include chemotherapy, radiation therapy, and surgery. Drugs used to treat bladder cancer are typically classified as either targeted therapies or immunotherapies. Targeted therapies are designed to target specific molecules or pathways in the body that are involved in the growth and spread of cancer cells. Immunotherapies are designed to stimulate the body’s own immune system to fight cancer cells. Some of the major companies in the Bladder Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and sale of drugs used to treat bladder cancer. Show Less Read more